ITT for observational data: Worst of both worlds?

Epidemiology

Volumn 19, Issue 6, 2008, Pages 783-784

  Stampfer, Meir J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

HEART DISEASE; HORMONAL THERAPY; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; NOTE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; BREAST TUMOR; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; ESTROGEN THERAPY; FEMALE; HEALTH SURVEY; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; OBSERVATION; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL ANALYSIS; TIME;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OBSERVATION; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS; TIME FACTORS;

EID: 61449442050     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318188442e     Document Type: Note

References (4)

1. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med. 2003;348:645-650.
2. Manson JE, Bassuk SS. Invited commentary: hormone therapy and risk of coronary heart disease - why renew the focus on the early years of menopause? Am J Epidemiol. 2007; 166:511-517.
3. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med. 2007;356:2639-2641.
4. Grodstein F, Manson JE, Stampfer MJ, Rexrode K. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med. 2008;168:861-866.